about
Evaluation of the vascular reaction in pharyngeal mucosa.15-year efficacy of uvulopalatopharyngoplasty based on objective and subjective data.A two-year weight reduction program in obese sleep apnea patientsObstructive sleep apnea syndrome in siblings: an 8-year Swedish follow-up studyEffectiveness of Oral Appliances in Obstructive Sleep Apnea with Respiratory Arousals.Trends and changes in paediatric tonsil surgery in Sweden 1987-2013: a population-based cohort study.Adenotonsillotomy Versus Adenotonsillectomy in Pediatric Obstructive Sleep Apnea: An RCT.Fetal CD103+ IL-17-Producing Group 3 Innate Lymphoid Cells Represent the Dominant Lymphocyte Subset in Human Amniotic Fluid.Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers.Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells.The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing.Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues.Questionnaire OSA-18 has poor validity compared to polysomnography in pediatric obstructive sleep apnea.SKUP3 randomised controlled trial: polysomnographic results after uvulopalatopharyngoplasty in selected patients with obstructive sleep apnoea.SKUP(3) : 6 and 24 months follow-up of changes in respiration and sleepiness after modified UPPP.Blood pressure after modified uvulopalatopharyngoplasty: results from the SKUP3 randomized controlled trial.Poor interexaminer agreement on Friedman tongue position.SKUP(3) RCT; continuous study: Changes in sleepiness and quality of life after modified UPPP.Authors' response to letter to the editor concerning our SKUP3 trial.Polygraphy vs. polysomnography: missing osas in symptomatic snorers--a reminder for clinicians.Pharyngeal disturbances in OSAS patients before and 1 year after UPPP.Uvulopalatopharyngoplasty in 158 OSAS patients failing non-surgical treatment.Heavy snorer's disease: a progressive local neuropathy.UPPP for habitual snoring: a 5-year follow-up with respiratory sleep recordings.Prostaglandin E2 suppresses human group 2 innate lymphoid cell function.Low inter-examiner agreement of the Friedman staging system indicating limited value in patient selection.Abnormal afferent nerve endings in the soft palatal mucosa of sleep apnoics and habitual snorersHistological indications of a progressive snorers disease in an upper airway muscleSleep patterns among patients with chronic fatigue: A polysomnography-based studyAdenopharyngoplasty vs Adenotonsillectomy in Children With Severe Obstructive Sleep Apnea: A Randomized Clinical TrialLong-term evaluation of satisfaction and side effects after modified uvulopalatopharyngoplasty
P50
Q32056875-82BD6263-891D-4BDC-A10D-9C34C9B3E459Q34072117-3F5E0F57-81EF-427C-AAF3-1621DBD7A25CQ34188874-D02A8EF2-DEB7-426A-B47F-AFC0466E885DQ36741782-1E4164C7-3478-4911-8AB6-7BAC70AD18F3Q37117701-831753AF-1C8D-4C0B-AA4B-1196E389DD53Q37598254-10281016-E521-47C7-B3CD-BC34F82156EFQ38892478-FA14587C-81A6-4630-97BC-A53163B5130FQ39425975-052F46DE-C163-44E3-B060-B296755AC33AQ40173120-437B562A-667D-447A-9B27-B9A55C9576D9Q40241403-21E8FC9C-2D21-438A-A5A2-50E5A59E1870Q40791214-A2962DF5-3D3E-4C69-BA22-327804B14AC7Q41044583-D2241199-0DFC-4A17-8DBD-04B2004B9203Q43490919-BD7D35A7-7AED-410B-8D75-DE8BDEF9E6B8Q45032994-67CC67BD-0766-4730-B385-3AB8215159FEQ47690483-B10C74F3-8E09-43DC-9257-128F2E375C5AQ47729676-EB21C7D8-1689-4189-929F-1DEDCFA9E167Q47791190-3A0F307E-A079-4302-8D50-CD93B15A4020Q47933650-95C2E5EF-678F-49BC-8D54-16C3EAD2D2FFQ48146339-170B71D6-CC60-423D-B1C2-7D9D906D0401Q48160880-838451D9-1E04-46AC-88A9-26DEA702473DQ48349267-0FB7722A-B276-435F-B7FE-F34E19B09673Q48384016-C046DA39-49A6-43A5-8E3F-7C51B8B44729Q48726979-B8628FAE-A227-4A6E-93B5-D267197259B3Q48820967-43A136FA-0A5C-4497-9783-34EC6ED43328Q50025252-E6EA4E4E-06B7-45FC-93D0-C92656E682C8Q52584074-3B4E73C3-F3C7-4A00-A30B-AB9D976C1B71Q73703299-7EF0A72A-F774-4E34-A225-0480AEE6E387Q74225481-A3B7DE8D-4897-4C1D-9525-09CBDA82439BQ88624311-7295FDA8-3F42-4417-8B47-6097A53A9785Q88933708-201DEB79-4700-4CB3-AE67-14C8A17EE850Q92300374-147DECF9-1E65-4F01-95E6-F65CF6164F49
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Danielle Friberg
@ast
Danielle Friberg
@en
Danielle Friberg
@es
Danielle Friberg
@nl
type
label
Danielle Friberg
@ast
Danielle Friberg
@en
Danielle Friberg
@es
Danielle Friberg
@nl
prefLabel
Danielle Friberg
@ast
Danielle Friberg
@en
Danielle Friberg
@es
Danielle Friberg
@nl
P106
P31
P496
0000-0001-8327-1292